新产品·新技术信息

雅宝在德克萨斯州的工厂增加其医疗产品的产能

来源：林中祥胶粘剂技术信息网2014年11月06日

阅读次数：次

Albemarle to Increase Production Capacity of Curative Products at its Pasadena Facility in Texas

BATON ROUGE, La. -- Albemarle Corporation (NYSE: ALB) a global developer, manufacturer and marketer of highly engineered specialty chemicals and services, announced that it plans to increase production capabilities of its curatives products at its facility in Pasadena, Texas. The capacity investment will support Albemarles ETHACURE 100 liquid curative product for application in polyureas, urethanes and epoxies.

Albemarles ETHACURE 100 curatives are effective curing agents and chain extenders for polyurethane and polyurea elastomers, as well as epoxy resins, particularly in reaction injection molding and spray applications. These diamine curatives allow for adjustable reaction time and substantially reduce dust exposure while providing processing advantages and improved final product properties.

"We are excited to announce our plans for increased production at a robust production site," said Chris Knight, Albemarles vice president, Specialty Chemicals. "This expansion will allow Albemarle to meet the needs of our customers by continuing to provide high quality products and customer service and will strengthen our position as a leading supplier in the curatives industry."

Production in the expanded facility is expected in 2015.

Albemarles ETHACURE product line is globally recognized for its effectiveness in curing polyurethanes, epoxies and polyureas. The curatives business is part of the Companys Performance Chemicals global business unit.